// App-Quantinova.ai

2482 : Hydroxychloroquine Has Lipid-Lowering Effects in US Veterans with Rheumatoid Arthritis

Researchers

Presenter

  • Nicole A. Kieffer

Principal Investigators

  • Gail S. Kerr

  • J. Steuart Richards

  • Lisa A. Davis

  • Liron Caplan

  • Jeffrey Huang

  • Grant W. Cannon

  • Harlan Sayles

  • Kaleb Michaud

Medical Centers

  • Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO

  • Div of Rheumatology, Denver VAMC and Univ of Colorado School of Medicine, Aurora, CO

  • Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

  • Rheumatology, Washington DC VA and Howard University Hospital, Washington, DC

  • Rheumatology, Washington DC VA and Georgetown University, Washington, DC

  • Division of Rheumatology, The George Washington University, Washington, DC

  • Rheumatology, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE

  • Division of Rheumatology, George E. Wahlen VA Medical Center, Salt Lake City, UT

  • Rheumatology, Washington DC VA and Georgetown University, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Rheumatoid arthritis

  • Diabetes

  • Inflammatory Arthritis

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • Hydroxychloroquine

  • Prednisone

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim